Correlation Between Bio Path and Histogen

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bio Path and Histogen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bio Path and Histogen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bio Path Holdings and Histogen, you can compare the effects of market volatilities on Bio Path and Histogen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bio Path with a short position of Histogen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bio Path and Histogen.

Diversification Opportunities for Bio Path and Histogen

-0.54
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Bio and Histogen is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding Bio Path Holdings and Histogen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Histogen and Bio Path is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bio Path Holdings are associated (or correlated) with Histogen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Histogen has no effect on the direction of Bio Path i.e., Bio Path and Histogen go up and down completely randomly.

Pair Corralation between Bio Path and Histogen

Given the investment horizon of 90 days Bio Path Holdings is expected to under-perform the Histogen. In addition to that, Bio Path is 2.86 times more volatile than Histogen. It trades about -0.01 of its total potential returns per unit of risk. Histogen is currently generating about 0.13 per unit of volatility. If you would invest  2.00  in Histogen on December 1, 2024 and sell it today you would earn a total of  0.70  from holding Histogen or generate 35.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy69.64%
ValuesDaily Returns

Bio Path Holdings  vs.  Histogen

 Performance 
       Timeline  
Bio Path Holdings 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Bio Path Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.
Histogen 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Over the last 90 days Histogen has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very weak basic indicators, Histogen displayed solid returns over the last few months and may actually be approaching a breakup point.

Bio Path and Histogen Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bio Path and Histogen

The main advantage of trading using opposite Bio Path and Histogen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bio Path position performs unexpectedly, Histogen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Histogen will offset losses from the drop in Histogen's long position.
The idea behind Bio Path Holdings and Histogen pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio